CTOs on the Move

Mat-Su Health

www.healthymatsu.org

 
The enjoyment of good health is fundamentally tied to the quality of life we enjoy here in the Mat-Su Borough. As such, Mat-Su Health Foundation`s focus in philanthropy is a natural extension of the historical work of Valley Hospital Association. The Mat-Su Health Foundation offers financial and strategic support to well-managed 501(c)(3) organizations that offer services and practical solutions to significant health-related problems impacting the citizens of the Mat-Su Borough. Some of our grant programs are open year-round, while others open for specific time periods. Please review our grant guidelines to see if your organization might be qualified to apply for ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Kelly Lewis
 Chief Operating Officer Profile

Similar Companies

Primewest Health System

Primewest Health System is a Alexandria, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aequor Healthcare

Aequor Healthcare is a Piscataway, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HealthLogic Systems Corporation

HealthLogic Systems Corporation is a Norcross, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Brown Fertility

Founded by Dr. Samuel Brown, Brown Fertility is a fully comprehensive fertility clinic offering patients exceptional results through personalized care and affordable treatment plans. With over 15 years experience and the management of more than 5,000 IVF cycles, Dr. Samuel Brown consistently achieves success rates above the national average. From basic evaluation and testing to the most advanced procedures and treatments available, Brown Fertility is dedicated to Conceiving Miracles™.

Histogenics

Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Histogenics` regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Histogenics` first investigational product candidate, NeoCart®, leverages its platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.